Эфриновые рецепторы при раке и эндометриозе
- Авторы: Файзуллин Л.З.1, Муфтайдинова Ш.К.1, Буралкина Н.А.1, Чупрынин В.Д.1
-
Учреждения:
- ФГБУ «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова» Минздрава России
- Выпуск: № 4 (2021)
- Страницы: 48-54
- Раздел: Статьи
- URL: https://journals.eco-vector.com/0300-9092/article/view/249179
- DOI: https://doi.org/10.18565/aig.202L4.48-54
- ID: 249179
Цитировать
Полный текст
Доступ предоставлен
Доступ платный или только для подписчиков
Аннотация
Ключевые слова
Полный текст
Об авторах
Леонид Закиевич Файзуллин
ФГБУ «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова» Минздрава Россиик.б.н., в.н.с. лаборатории молекулярно-генетических методов
Шахноза Киёмиддиновна Муфтайдинова
ФГБУ «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова» Минздрава России
Email: shaxnozka_87@mail.ru
аспирант
Наталья Александровна Буралкина
ФГБУ «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова» Минздрава России
Email: n_buralkina@oparina4.ru
д.м.н., с.н.с., хирургическое отделение отдела оперативной гинекологии и общей хирургии
Владимир Дмитриевич Чупрынин
ФГБУ «Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова» Минздрава России
Email: v_chuprinin@oparina4.ru
к.м.н., заведующий хирургическим отделением отдела оперативной гинекологии и общей хирургии
Список литературы
- Herreros-Villanueva M., Chen C.C., Tsai E.M., Er T.K. Endometriosis-associated ovarian cancer: What have we learned so far? Clin. Chim. Acta. 2019; 493: 63-72. https://dx.doi.org/10.1016/j.cca.2019.02.016.
- Kajiyama H., Suzuki S., Yoshihara M., Tamauchi S., Yoshikawa N., Niimi K. et al. Endometriosis and cancer. Free Radic. Biol. Med. 2019; 133: 186-92. https:// dx.doi.org/10.1016/j.freeradbiomed.2018.12.015.
- Samani E.N., Mamillapalli R., Li F., Mutlu L., Hufnagel D., Krikun G., Taylor H.S. Micrometastasis of endometriosis to distant organs in a murine model. Oncotarget. 2017; 10(23): 2282-91. https://dx.doi.org/10.18632/ oncotarget.16889. eCollection 2019 Mar 19.
- Ruderman R., Pavone M.E. Ovarian cancer in endometriosis: an update on the clinical and molecular aspects. Minerva Ginecol. 2017; 69(3): 286-94. https:// dx.doi.org/10.23736/S0026-4784.17.04042-4.
- Wei J.J., William J., Bulun S. Endometriosis and ovarian cancer: a review of clinical, pathologic, and molecular aspects. Int. J. Gynecol. Pathol. 2011; 30(6): 553-68. https://dx.doi.org/10.1097/PGP.0b013e31821f4b85.
- Nezhat F.R., Apostol R., Nezhat C., Pejovic T. New insights in the pathophysiology of ovarian cancer and implications for screening and prevention. Am. J. Obstet. Gynecol. 2015; 213(3): 262-7. https://dx.doi.org/10.1016/ j.ajog.2015.03.044.
- Yang C., Oh H.K., Kim D. Mullerian adenosarcoma arising from rectal endometriosis. Ann. Coloproctol. 2014; 30(5): 232-6. https://dx.doi. org/10.3393/ac.2014.30.5.232.
- Masand R.P., Euscher E.D., Deavers M.T., Malpica A. Endometrioid stromal sarcoma: a clinicopathologic study of 63 cases. Am. J. Surg. Pathol. 2013; 37(11): 1635-47. https://dx.doi.org/10.1097/PAS.0000000000000083.
- Anglesio M.S., Bashashati A., Wang Y.K., Senz J., Ha G., Yang W. et al. Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden. J. Pathol. 2015; 236(2): 201-9. https://dx.doi.org/10.1002/path.4516.
- Yu H.C., Lin C.Y., Chang W.C., Shen B.J., Chang W.P., Chuang C.M. Increased association between endometriosis and endometrial cancer: a nationwide population-based retrospective cohort study. Int. J. Gynecol. Cancer. 2015; 25(3): 447-52. https://dx.doi.org/10.1097/ IGC.0000000000000384.
- Samartzis E.P., Noske A., Dedes K.J., Fink D., Imesch P. ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas. Int. J. Mol. Sci. 2013; 14(9): 18824-49. https:// dx.doi.org/10.3390/ijms140918824.
- Borghese B., Zondervan K.T., Abrao M.S., Chapron C., Vaiman D. Recent insights on the genetics and epigenetics of endometriosis. Clin. Genet. 2017; 91(2): 254-64. https://dx.doi.org/10.1111/cge.12897.
- Anglesio M.S., Papadopoulos N., Ayhan A., Nazeran T.M., Noe M., Horlings H.M. et al. Cancer-associated mutations in endometriosis without cancer. N. Engl. J. Med. 2017; 376(19): 1835-48. https://dx.doi.org/10.1056/NEJMoa1614814.
- Grassi T., Calcagno A., Marzinotto S., Londero A.P., Orsaria M., Canciani G.N. et al. Mismatch repair system in endometriotic tissue and eutopic endometrium of unaffected women. Int. J. Clin. Exp. Pathol. 2015; 8(2): 1867-77.
- Jiang L., Yan Y., Liu Z., Wang Y. Inflammation and endometriosis. Front. Biosci. (Landmark Ed). 2016; 21: 941-8. https://dx.doi.org/10.2741/4431.
- Samimi M., Pourhanifeh M.H., Mehdizadehkashi A., Eftekhar T., Asemi Z. The role of inflammation, oxidative stress, angiogenesis, and apoptosis in the pathophysiology of endometriosis: Basic science and new insights based on gene expression. J. Cell. Physiol. 2019; 234(11): 19384-92. https://dx.doi. org/10.1002/jcp.28666.
- Symons L.K., Miller J.E., Kay V.R., Marks R.M., Liblik K., Koti M., Tayade C. The immunopathophysiology of endometriosis. Trends Mol. Med. 2018; 24(9): 748-62. https://dx.doi.org/10.1016/j.molmed.2018.07.004.
- Si kora J., Smycz-Kubanska M., Mielczarek-Palacz A., Kondera-Anasz Z. Abnormal peritoneal regulation of chemokine activation - the role of IL-8 in pathogenesis of endometriosis. Am. J. Reprod. Immunol. 2017; 77(4): e12622. https://dx.doi.org/10.1111/aji.12622.
- Taylor H., Campbell J., Nobes C.D. Ephs and ephrins. Curr. Biol. 2017; 27(3): R90-5. https://dx.doi.org/10.1016/j.cub.2017.01.003.
- Kania A., Klein R. Mechanisms of ephrin-Eph signalling in development, physiology and disease. Nat. Rev. Mol. Cell Biol. 2016; 17(4): 240-56. https:// dx.doi.org/10.1038/nrm.2015.16.
- Pasquale E.B. Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat. Rev. Cancer. 2010; 10(3): 165-80. https://dx.doi.org/10.1038/ nrc2806.
- Fagotto F, Winklbauer R., Rohani N. Ephrin-Eph signaling in embryonic tissue separation. Cell Adh. Migr. 2014; 8(4): 308-26. https://dx.doi.org/10.4161/ 19336918.2014.970028.
- Liang L.Y., Patel O., Janes P.W., Murphy J.M., Lucet I.S. Eph receptor signalling: from catalytic to non-catalytic functions. Oncogene. 2019; 38(39): 6567-84. https://dx.doi.org/10.1038/s41388-019-0931-2.
- Chen J. Regulation of tumor initiation and metastatic progression by Eph receptor tyrosine kinases. Adv. Cancer Res. 2012; 114: 1-20. https:// dx.doi.org/10.1016/B978-0-12-386503-8.00001-6.
- Kaenel P., Mosimann M., Andres A.C. The multifaceted roles of Eph/Ephrin signaling in breast cancer. Cell Adh. Migr. 2012; 6(2): 138-47. https:// dx.doi.org/10.4161/cam.20154.
- Ieguchi K., Maru Y. Roles of EphA1/A2 and ephrin-A1 in cancer. Cancer Sci. 2019; 110(3): 841-8. https://dx.doi.org/10.1111/cas.13942.
- Yang N.Y., Fernandez C., RichterM., Xiao Z., Valencia F., Tice D.A., Pasquale E.B. Crosstalk of the EphA2 receptor with a serine/threonine phosphatase suppresses the Akt-mTORC1 pathway in cancer cells. Cell. Signals. 2011; 23(1): 201-12. https://dx.doi.org/10.1016/j.cellsig.2010.09.004.
- Miao H., Gale N.W, Guo H., Qian J., Petty A., Kaspar J. et al. EphA2 promotes infiltrative invasion of glioma stem cells in vivo through cross-talk with Akt and regulates stem cell properties. Oncogene. 2015; 34(5): 558-67. https:// dx.doi.org/10.1038/onc.2013.590.
- Tarasov V.V., Svistunov A.A., Chubarev V.N., Zatsepilova T.A., Preferanskaya N.G., Stepanova O.I. et al. Feasibility of targeting glioblastoma stem cells: from concept to clinical trials. Curr. Top. Med. Chem. 2019; 19(32): 2974-84. https:// dx.doi.org/10.2174/1568026619666191112140939.
- Cui Y., Wu B.O., Flamini V., Evans B.A.J., Zhou D., Jiang W.G. Knockdown of EPHA1 using CRISPR/CAS9 suppresses aggressive properties of ovarian cancer cells. Anticancer Res. 2017; 37(8): 4415-24. https://dx.doi.org/10.21873/ anticanres.11836.
- Janes P.W., Slape C.I., Farnsworth R.H., Atapattu L., Scott A.M., Vail M.E. EphA3 biology and cancer. Growth Factors. 2014; 32(6): 176-89. https://dx.doi.org/10. 3109/08977194.2014.982276.
- Lv X.Y., Wang J, Huang F., Wang P., Zhou J.G., Wei B., Li S.H. EphA3 contributes to tumor growth and angiogenesis in human gastric cancer cells. Oncol. Rep. 2018; 40(4): 2408-16. https://dx.doi.org/10.3892/or.2018.6586.
- Toyama M., Hamaoka Y., Katoh H. EphA3 is up-regulated by epidermal growth factor and promotes formation of glioblastoma cell aggregates. Biochem. Biophys. Res. Commun. 2019; 508(3): 715-21. https://dx.doi.org/10.1016/ j.bbrc.2018.12.002.
- Peng J., Wang Q., Liu H., Ye M., Wu X., Guo L. EPHA3 regulates the multidrug resistance of small cell lung cancer via the PI3K/BMX/STAT3 signaling pathway. Tumour Biol. 2016; 37(9): 11959-71. https://dx.doi.org/10.1007/ s13277-016-5048-4.
- Liu C., Huang H., Wang C., Kong Y., Zhang H. Involvement of ephrin receptor A4 in pancreatic cancer cell motility and invasion. Oncol. Lett. 2014; 7(6): 2165 9. https://dx.doi.org/10.3892/ol.2014.2011
- Saintigny P., Peng S., Zhang L., Sen B., Wistuba I.I., Lippman S.M. et al. Global evaluation of Eph receptors and ephrins in lung adenocarcinomas identifies EphA4 as an inhibitor of cell migration and invasion. Mol. Cancer Ther. 2012; 11(9): 2021-32. https://dx.doi.org/10.1158/ 1535-7163.MCT-12-0030.
- Giaginis C., Tsoukalas N., Bournakis E., Alexandrou P., Kavantzas N., Patsouris E., Theocharis S. Ephrin (Eph) receptor A1, A4, A5 and A7 expression in human non-small cell lung carcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients' survival. BMC Clin. Pathol. 2014; 14(1): 8. https://dx.doi.org/10.1186/ 1472-6890-14-8.
- Zhang W., Wei X., Guo S., Wang J., Liu J., Wang H. Differential expression of EphA5 protein in gastric carcinoma and its clinical significance. Oncol. Lett. 2019; 17(6): 5147-53. https://dx.doi.org/10.3892/ol.2019.10167.
- Li R., Sun Y., Jiang A., Wu Y., Li C., Jin M. et al. Knockdown of ephrin receptor A7 suppresses the proliferation and metastasis of A549 human lung cancer cells. Mol. Med. Rep. 2016; 13(4): 3190-6. https://dx.doi.org/10.3892/ mmr.2016.4904.
- Chen Y., Zhang H., Zhang Y. Targeting receptor tyrosine kinase EphB4 in cancer therapy. Semin. Cancer Biol. 2019; 56: 37-46. https://dx.doi.org/10.1016/ j.semcancer.2017.10.002.
- Nikas I., Ryu H.S., Theocharis S. Viewing the Eph receptors with a focus on breast cancer heterogeneity. Cancer Lett. 2018; 434: 160-71. https:// dx.doi.org/10.1016/j.canlet.2018.07.030.
- Mateo-Lozano S., Bazzocco S., Rodrigues P., Mazzolini R., Andretta E., Dopeso H. et al. Loss of the EPH receptor B6 contributes to colorectal cancer metastasis. Sci. Rep. 2017; 7: 43702. https://dx.doi.org/10.1038/srep43702.
- El Zawily A., McEwen E., Toosi B., Vizeacoumar F.S., Freywald T., Vizeacoumar F.J., Freywald A. The EphB6 receptor is overexpressed in pediatric T cell acute lymphoblastic leukemia and increases its sensitivity to doxorubicin treatment. Sci. Rep. 2017; 7(1): 14767. https://dx.doi.org/10.1038/s41598-017-15200-3.
- Fujiiwara H., Tatsumi K., Kosaka K., Yoshioka S., Fujiwara H., Fujii S. Ephephrin A system regulates murine blastocyst attachment and spreading. Dev. Dyn. 2006; 235(12): 3250-8. https://dx.doi.org/10.1002/dvdy.20977.
- Fujiwara H., Yoshioka S., Tatsumi K., Kosaka K., Satoh Y., Nishioka Y. et al. Human endometrial epithelial cells express ephrin A1: possible interaction between human blastocysts and endometrium via Eph-ephrin system. J. Clin. Endocrinol. Metab. 2002; 87(12): 5801-7. https://dx.doi.org/10.1210/ jc.2002-020508.
- Fujii H., Fujiwara H., Horie A., Sato Y., Konishi I. Ephrin A1 induces intercellular dissociation in Ishikawa cells: possible implication of the Ephephrin A system in human embryo implantation. Hum. Reprod. 2011; 26(2): 299-306. https:// dx.doi.org/10.1093/humrep/deq340.
- Shchegolev A., Muftaydinova S., Fayzullina N.M., Buralkina N., Fayzullin L.Z., Chuprynin V.D. Overexpression of ephrin receptor a2 in the ectopic endometrium of patients with deep infiltrative endometriosis. Virchow’s Archiv. 2019; 475(Suppl. 1): S318.
- Kao L.C., GermeyerA., Tulac S., Lobo S., Yang J.P., Taylor R.N. et al. Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology. 2003; 144(7): 2870-81. https://dx.doi.org/10.1210/en.2003-0043.
- Xu H., Gao Y., Shu Y., Wang Y., Shi Q. EPHA3 enhances macrophage autophagy and apoptosis by disrupting the mTOR signaling pathway in mice with endometriosis. Biosci. Rep. 2019; 39(7): BSR20182274. https:// dx.doi.org/10.1042/BSR20182274.
- Saha N., Robev D., Mason E.O., Himanen J.P., Nikolov D.B. Therapeutic potential of targeting the Eph/ephrin signaling complex. Int. J. Biochem. Cell Biol. 2018; 105: 123-33. https://dx.doi.org/10.1016/j.biocel.2018.10.006.
- Lodola A., Giorgio C., Incerti M., Zanotti I., Tognolini M. Targeting Eph/ephrin system in cancer therapy. Eur. J. Med. Chem. 2017; 142: 152-62. https:// dx.doi.org/10.1016/j.ejmech.2017.07.029.
- Zondervan K.T., Becker C.M., Missmer S.A. Endometriosis. N. Engl. J. Med. 2020; 382(13): 1244-56. https://dx.doi.org/10.1056/NEJMra1810764.
- Arcoverde F.V.L., Andres M.P., Borrelli G.M., Barbosa P. A., Abrao M.S., Kho R.M. Surgery for endometriosis improves major domains of quality of life: a systematic review and meta-analysis. J. Minim. Invasive Gynecol. 2019; 26: 266-78.
- Bendifallah S., Vesale E., Darai E., Thomassin-Naggara I., Bazot M., Tuech J.J. et al. Recurrence after surgery for colorectal endometriosis: A systematic review and meta-analysis. J. Minim. Invasive Gynecol. 2020; 27(2): 441-51. e2. https:// dx.doi.org/10.1016/j.jmig.2019.09.791.
- Rudzitis-Auth J., Fufl S.A., Becker V., Menger M.D., Laschke M.W. Inhibition of erythropoietin-producing hepatoma receptor B4 (EphB4) signalling suppresses the vascularisation and growth of endometriotic lesions. Br. J. Pharmacol. 2020; 177(14): 3225-39. https://dx.doi.org/10.1111/bph.15044.